Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
BMJ Case Reports|November 16, 2013
Ranibizumab in choroidal neovascularisation associated with ocular sarcoidosisVasileios Efstathios Konidaris, Theodoros EmpeslidisInternational Ophthalmology|January 30, 2023
The developments in amniotic membrane transplantation in glaucoma and vitreoretinal proceduresRohit Sharma, Vivian Nappi, Theodoros EmpeslidisCase Reports in Ophthalmology|April 25, 2012
Intravitreal ranibizumab in the treatment of butterfly-shaped pattern dystrophy associated with choroidal neovascularization: a case reportTheodoros Empeslidis, Athanasios Vardarinos, James Deane, et al.Oman Journal of Ophthalmology|November 10, 2017
Bilateral sensorineural hearing loss secondary to sympathetic ophthalmia in a human leukocyte antigen-A2 positive patientKonstantinos T Tsaousis, Vasileios E Konidaris, Theodoros EmpeslidisBMJ Case Reports|August 5, 2017
Bilateral choroidal neovascular membrane in a young patient with Sorsby fundus dystrophy: the value of prompt treatmentNardine Menassa, Sreekala Burgula, Theodoros Empeslidis, et al.Ocular Immunology and Inflammation|December 17, 2013
Fourth cranial nerve palsy and bilateral acute retinal necrosis following human herpesvirus 6 infection of the central nervous systemEleni Papageorgiou, Soon Ch'ng, Archana Kulkarni, et al.European Journal of Ophthalmology|May 11, 2013
Dexamethasone intravitreal implant for idiopathic retinal vasculitis, aneurysms, and neuroretinitisTheodoros Empeslidis, Somnath Banerjee, Athanasios Vardarinos, et al.Expert Opinion on Drug Discovery|September 5, 2025
In silico trials in ocular drug development: a new frontier in ophthalmologyGeorgios D Panos, Gordon N Dutton, Theodoros Empeslidis, et al.Ophthalmic Genetics|September 30, 2014
Use of Intravitreal Bevacizumab in a 9-Year-Old Child with Choroidal Neovascularization Associated with Autosomal Recessive BestrophinopathyRumana N Hussain, Fatema L Shahid, Theodoros Empeslidis, et al.Ophthalmology and Therapy|November 12, 2017
Real-World Cost Savings Demonstrated by Switching Patients with Refractory Diabetic Macular Edema to Intravitreal Fluocinolone Acetonide (Iluvien): A Retrospective Cost Analysis StudySoon W Ch'ng, Alexander J Brent, Theodoros Empeslidis, et al.Pageof 3